TitleDatePubMed ID
Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors.2012 Mar22238126
Cascade detection for the extraction of localized sequence features; specificity results for HIV-1 protease and structure-function results for the Schellman loop.2011 Dec 1522039211
Design, synthesis, and X-ray crystallographic analysis of a novel class of HIV-1 protease inhibitors.2011 Oct 2721916489
Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope.2011 Jul 2221762811
Insights into the dynamics of HIV-1 protease: a kinetic network model constructed from atomistic simulations.2011 Jun 2221561098
Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands.2011 Jun 1521555220
Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation.2011 Jan 2721194227
Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity.2011 Jan 1721109032
Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones.2010 Nov 1120958050
Effects of the V82A and I54V mutations on the dynamics and ligand binding properties of HIV-1 protease.2010 Oct20195662